Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+13.8%
5Y CAGR+24.2%
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+13.8%/yr
Annual compound
5Y CAGR
+24.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$5.21M+133.5%
2023$2.23M-11.6%
2022$2.52M-28.5%
2021$3.53M-10.2%
2020$3.93M+122.9%
2019$1.76M-
2018$0.00-
2017$0.00-